WAKAYAMA MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1945-01-01
- Employees
- -
- Market Cap
- -
Change in Plaque Characteristics With Atorvastatin
Phase 4
Completed
- Conditions
- AtherosclerosisAcute Coronary SyndromeDyslipidemia
- Interventions
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 70
- Registration Number
- NCT00700037
- Locations
- 🇯🇵
Wakayama Medical University, Wakayama, Japan
Phaseâ… /â…¡ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer
Phase 1
- Conditions
- Esophageal Cancer
- First Posted Date
- 2008-04-30
- Last Posted Date
- 2010-09-09
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 29
- Registration Number
- NCT00669292
- Locations
- 🇯🇵
Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, Wakayama, Japan
Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy
Not Applicable
Completed
- Conditions
- Pancreatic CancerBile Duct CancerAmpullary CancerDuodenal CancerPancreatitis
- Interventions
- Procedure: pylorus-resecting pancreaticoduodenectomyProcedure: pylorus-preserving pancreaticoduodenectomy
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 130
- Registration Number
- NCT00639314
- Locations
- 🇯🇵
Second Department of Surgery, Wakayama Medical University, School of Medicine, 811-1 Kimiidera, Wakayama, Japan
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy
Not Applicable
Completed
- Conditions
- Bile Duct CancerPancreatitisDuodenal CancerPancreatic CancerAmpullary Cancer
- Interventions
- Device: external drainage tube [polyethylene pancreatic drainage tube]Device: internal drainage tube [polyethylene pancreatic drainage tube]
- First Posted Date
- 2008-03-04
- Last Posted Date
- 2010-01-18
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT00628186
- Locations
- 🇯🇵
Wakayama Medical University , Second Department of Surgery, 811-1 Kimiidera, Wakayama, Wakayama, Japan
Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- Biological: VEGFR2-169 and gemcitabine
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2009-02-18
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 21
- Registration Number
- NCT00622622
- Locations
- 🇯🇵
Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, Wakayama, Japan
© Copyright 2025. All Rights Reserved by MedPath